The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

See what infectious disease doctors have to say as government officials appear poised to scale back COVID vaccines and the ...

Federal health agencies were alerted in February 2021 to “large reports of myocarditis” in young people who received the Pfizer vaccine, but waited until late June to adjust the ...

The change was announced by the Food and Drug Administration, which falls under Health and Human Services. While Secretary ...

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

Presented by The Coalition to Strengthen America’s Healthcare — The Trump administration on Tuesday said it plans to limit ...

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...